To include your compound in the COVID-19 Resource Center, submit it here.

Daiichi Sankyo, AstraZeneca to co-promote denosumab

Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568) partnered with AstraZeneca plc (LSE:AZN; NYSE:AZN)

Read the full 129 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE